Lexaria Bioscience Corp (LEXX) earnings · rev $705.9K
Lexaria Bioscience Corp (LEXX) is a biotechnology company listed on US.
This LEXX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LEXX revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXX currently screens at market cap $14.9M.
When the next LEXX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 52.0% from 2024-08-31 to 2025-08-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LEXX research stays on the stock page; the tape stays on the quote page.
Not investment advice.